Appointments: Shire, Bicycle Therapeutics, Gilead Sciences, Astellas, Alzheon, Alnylam and Amplyx

06 Jan 2017

• By Lubna Ahmed

2017 begins with three Novartis executives finding new roles and high-level appointments made by Shire, Bicycle Therapeutics, Gilead Science and Amplyx Pharmaceuticals.

Appointments: Shire, Bicycle Therapeutics, Gilead Sciences, Astellas, Alzheon, Alnylam and Amplyx

More from Executives On The Move

More from Leadership